Support our research activities. We appreciate your personal contribution.​

DONATIONS

PrivatELY aND PUBLICALLY  FUNDED CLINICAL STUDIES WORLDWIDE​

3.899 studies on immunotherapiy

76.597 studies on oncology​

clinicaltrails.gov/6.2019​

2019: Of around 80,000 international studies in oncology, only about 20% are in the field of immunotherapy. Due to the high degree of personalization of the treatment, it does not promise the high returns of a mass-produced medication. 
 
That it is why it is so important that private contributions support the research into these innovative therapies. Although the IOZK Foundation does benefit from some public funding for its projects, we can reach our research goals much faster and more effectively with private funding.

 

If you are interested in the activities of the IOZK Foundation, please contact us:

 

Dr. Wilfried Stücker, CEO IOZK Foundation
Stefaan Van Gool, MD. PhD.
Arnd Slegers


Phone +49 (0)221 420 399 5

Support our research activities. We appreciate your personal contribution.

2019: Of around 80,000 international studies in oncology, only about 20% are in the field of immunotherapy. Due to the high degree of personalization of the treatment, it does not promise the high returns of a mass-produced medication. 
 
That it is why it is so important that private contributions support the research into these innovative therapies. Although the IOZK Foundation does benefit from some public funding for its projects, we can reach our research goals much faster and more effectively with private funding.

 

If you are interested in the activities of the IOZK Foundation, please contact us:

 

Dr. Wilfried Stücker, CEO IOZK Foundation

 

Stefaan Van Gool, MD. PhD.

 

Arnd Slegers

 

Phone: +49 (0)221 420 399 51

PRIVATELY AND PUBLICALLY  FUNDED CLINICAL STUDIES WORLDWIDE​

de   eng